SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-22-021768
Filing Date
2022-04-27
Accepted
2022-04-27 07:00:55
Documents
4
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea158910-def14a_hoththerape.htm DEF 14A 609279
2 GRAPHIC image_001.jpg GRAPHIC 8998
3 GRAPHIC proxy_001.jpg GRAPHIC 78401
4 GRAPHIC proxy_002.jpg GRAPHIC 71342
  Complete submission text file 0001213900-22-021768.txt   829221
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38803 | Film No.: 22856256
SIC: 2834 Pharmaceutical Preparations